30 July 2024 - Marius Pharmaceuticals is pleased to announce the submission of its new drug submission for Kyzatrex (testosterone undecanoate) capsules to Health Canada for approval. 

This submission marks the company's first international filing, with an anticipated approval date in Q2 of 2025.

Read Marius Pharmaceuticals press release